On March 11, 2019, the WHO declared COVID-19 a pandemic disease. It is a respiratory tropism SARS COV 2 infection. In the emergency of the pandemic, in medical imaging, only computed tomography (CT) of the lungs was f...On March 11, 2019, the WHO declared COVID-19 a pandemic disease. It is a respiratory tropism SARS COV 2 infection. In the emergency of the pandemic, in medical imaging, only computed tomography (CT) of the lungs was favored to assess lung lesions. In addition, many cases of post-COVID-19 cognitive disorders have been reported. As the curve dips and services restart correctly, other imaging techniques have been used to better explore the disease. The objective of this presentation is to illustrate the contribution of metabolic imaging in the exploration of post COVID-19 cognitive disorders and to discuss the pathophysiological mechanisms. Hypometabolism brain lesions are objective signs of functional impairment whose pathophysiological mechanism is not yet fully understood. Metabolic imaging with PET-SCAN is a suitable tool for exploring these disorders, both for the severity and extent of the lesions and for the topography of the brain damage.展开更多
目的研究和估算在成人体部PET/CT显像中,应用自动毫安(ATCM)技术进行CT扫描时患者所接受的X射线及18F-FDG所致辐射的总有效剂量。方法选取71例(男41例,女30例)接受体部PET/CT显像的成人患者(≥18岁),利用计算机自动给出的剂量长度乘积...目的研究和估算在成人体部PET/CT显像中,应用自动毫安(ATCM)技术进行CT扫描时患者所接受的X射线及18F-FDG所致辐射的总有效剂量。方法选取71例(男41例,女30例)接受体部PET/CT显像的成人患者(≥18岁),利用计算机自动给出的剂量长度乘积值估算ATCM条件下CT扫描所致辐射的有效剂量,并根据ICRP推荐的方法估算18F-FDG所致辐射的有效剂量,由此得出成人单次体部PET/CT显像所受辐射的总有效剂量。结果成人受检者行单次PET/CT显像时,CT扫描所致辐射的有效剂量为4.8~13.5 m Sv,平均(6.8±1.9)m Sv;患者注射18F-FDG所致辐射的有效剂量为3.8~9.0 m Sv,平均(6.0±1.0)m Sv;由此得出,单次体部PET/CT显像所致辐射的总有效剂量为10.3~21.3 m Sv,平均(12.8±2.2)m Sv。结论采用ATCM技术进行成人单次体部PET/CT显像时,CT扫描所致辐射的有效剂量约占总有效剂量的53.0%,表明应用ATCM技术可以在一定程度上减少受检者所受CT辐射剂量,从而能够降低受检者所受辐射的总有效剂量。展开更多
文摘On March 11, 2019, the WHO declared COVID-19 a pandemic disease. It is a respiratory tropism SARS COV 2 infection. In the emergency of the pandemic, in medical imaging, only computed tomography (CT) of the lungs was favored to assess lung lesions. In addition, many cases of post-COVID-19 cognitive disorders have been reported. As the curve dips and services restart correctly, other imaging techniques have been used to better explore the disease. The objective of this presentation is to illustrate the contribution of metabolic imaging in the exploration of post COVID-19 cognitive disorders and to discuss the pathophysiological mechanisms. Hypometabolism brain lesions are objective signs of functional impairment whose pathophysiological mechanism is not yet fully understood. Metabolic imaging with PET-SCAN is a suitable tool for exploring these disorders, both for the severity and extent of the lesions and for the topography of the brain damage.
文摘目的研究和估算在成人体部PET/CT显像中,应用自动毫安(ATCM)技术进行CT扫描时患者所接受的X射线及18F-FDG所致辐射的总有效剂量。方法选取71例(男41例,女30例)接受体部PET/CT显像的成人患者(≥18岁),利用计算机自动给出的剂量长度乘积值估算ATCM条件下CT扫描所致辐射的有效剂量,并根据ICRP推荐的方法估算18F-FDG所致辐射的有效剂量,由此得出成人单次体部PET/CT显像所受辐射的总有效剂量。结果成人受检者行单次PET/CT显像时,CT扫描所致辐射的有效剂量为4.8~13.5 m Sv,平均(6.8±1.9)m Sv;患者注射18F-FDG所致辐射的有效剂量为3.8~9.0 m Sv,平均(6.0±1.0)m Sv;由此得出,单次体部PET/CT显像所致辐射的总有效剂量为10.3~21.3 m Sv,平均(12.8±2.2)m Sv。结论采用ATCM技术进行成人单次体部PET/CT显像时,CT扫描所致辐射的有效剂量约占总有效剂量的53.0%,表明应用ATCM技术可以在一定程度上减少受检者所受CT辐射剂量,从而能够降低受检者所受辐射的总有效剂量。
